Sensus Healthcare Inc
NASDAQ:SRTS

Watchlist Manager
Sensus Healthcare Inc Logo
Sensus Healthcare Inc
NASDAQ:SRTS
Watchlist
Price: 4.96 USD
Market Cap: 81.5m USD
Section:
 

Relative Value

The Relative Value of one SRTS stock under the Base Case scenario is hidden USD. Compared to the current market price of 4.96 USD, Sensus Healthcare Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SRTS Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

2.3
P/S
P/S
Price to Sales
2.3
vs History
60
vs Industry
48
Median 3Y
2
Median 5Y
2.7
Industry
2.4
Forward
2.6
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
37
Median 3Y
12.1
Median 5Y
7.1
Industry
22.9
Forward
-14.2
More Details
42.7
P/OCF
P/OCF
Price to OCF
42.7
vs History
11
vs Industry
Median 3Y
-4.3
Median 5Y
-4.3
Industry
14.7
More Details
37.6
P/FCFE
P/FCFE
Price to FCFE
37.6
vs History
17
vs Industry
Median 3Y
-4.1
Median 5Y
-4.1
Industry
21.4
More Details
1.6
P/B
P/B
Price to Book Value
1.6
vs History
61
vs Industry
52
Median 3Y
1.5
Median 5Y
2
Industry
2.3
More Details
1.6
EV/S
EV/S
Enterprise Value to Sales
1.6
vs History
63
vs Industry
59
Median 3Y
1.5
Median 5Y
2.2
Industry
2.6
Forward
1.8
More Details
3.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.3
vs History
52
vs Industry
65
Median 3Y
2.5
Median 5Y
3.4
Industry
5.3
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
43
Median 3Y
6.8
Median 5Y
6.9
Industry
12.3
Forward
-6.6
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
43
Median 3Y
7
Median 5Y
6.5
Industry
17.2
Forward
-6.5
More Details
29.9
EV/OCF
EV/OCF
Enterprise Value to OCF
29.9
vs History
14
vs Industry
Median 3Y
-2.4
Median 5Y
-2.4
Industry
15
More Details
26.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
26.3
vs History
19
vs Industry
Median 3Y
-2.3
Median 5Y
-2.3
Industry
19
More Details
2
EV/IC
EV/IC
Enterprise Value to IC
2
vs History
58
vs Industry
43
Median 3Y
1.7
Median 5Y
2.6
Industry
1.9
More Details

Multiples Across Competitors

SRTS Competitors Multiples
Sensus Healthcare Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Sensus Healthcare Inc
NASDAQ:SRTS
81.5m USD 2.3 -27.1 -11 -10.5
US
Abbott Laboratories
NYSE:ABT
212.6B USD 4.8 15.2 19.4 27
US
Intuitive Surgical Inc
NASDAQ:ISRG
192.2B USD 20 70.1 53.5 65.3
US
Stryker Corp
NYSE:SYK
138.2B USD 5.7 47.3 22.9 27.7
US
Boston Scientific Corp
NYSE:BSX
131.5B USD 6.8 47.3 27.7 37.6
IE
Medtronic PLC
NYSE:MDT
125.6B USD 3.6 26.3 14.8 21.5
DE
Siemens Healthineers AG
XETRA:SHL
51.9B EUR 2.2 24.2 13.6 19.2
US
Becton Dickinson and Co
NYSE:BDX
59.1B USD 2.7 35.5 12.9 21.9
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57B USD 13.7 55.6 39.8 44.1
US
Edwards Lifesciences Corp
NYSE:EW
49B USD 8.3 35.7 25.6 28
US
Resmed Inc
NYSE:RMD
37.8B USD 7.2 26.3 18.9 20.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Sensus Healthcare Inc
NASDAQ:SRTS
Average EV/EBITDA: 24.9
Negative Multiple: -11
-13%
N/A
US
Abbott Laboratories
NYSE:ABT
19.4
12%
1.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
53.5
26%
2.1
US
Stryker Corp
NYSE:SYK
22.9
13%
1.8
US
Boston Scientific Corp
NYSE:BSX
27.7
22%
1.3
IE
Medtronic PLC
NYSE:MDT
14.8
8%
1.9
DE
Siemens Healthineers AG
XETRA:SHL
13.6
11%
1.2
US
Becton Dickinson and Co
NYSE:BDX
12.9
9%
1.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.8
14%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
25.6
13%
2
US
Resmed Inc
NYSE:RMD
18.9
11%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Sensus Healthcare Inc
NASDAQ:SRTS
Average EV/EBIT: 31.3
Negative Multiple: -10.5
-32%
N/A
US
Abbott Laboratories
NYSE:ABT
27
22%
1.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
65.3
28%
2.3
US
Stryker Corp
NYSE:SYK
27.7
16%
1.7
US
Boston Scientific Corp
NYSE:BSX
37.6
32%
1.2
IE
Medtronic PLC
NYSE:MDT
21.5
17%
1.3
DE
Siemens Healthineers AG
XETRA:SHL
19.2
15%
1.3
US
Becton Dickinson and Co
NYSE:BDX
21.9
21%
1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
44.1
15%
2.9
US
Edwards Lifesciences Corp
NYSE:EW
28
13%
2.2
US
Resmed Inc
NYSE:RMD
20.9
12%
1.7

See Also

Summary
SRTS intrinsic value, competitors valuation, and company profile.
DCF Valuation
SRTS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SRTS stock valuation using valuation multiples.
Wall Street Estimates
SRTS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SRTS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 310,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.